Apolipoprotein E ε4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease

Annals of Internal Medicine

Volumn 137, Issue 3, 2002, Pages 149-155

  Kivipelto, Miia ^a   Helkala, Eeva Liisa ^a   Laakso, Mikko P ^a   Hänninen, Tuomo ^a   Hallikainen, Merja ^a   Alhainen, Kari ^a   Iivonen, Susan ^a   Mannermaa, Arto ^a   Tuomilehto, Jaakko ^a   Nissinen, Aulikki ^a   Soininen, Hilkka ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; CHOLESTEROL; APOLIPOPROTEIN E;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DEMENTIA; FEMALE; FINLAND; FOLLOW UP; GENETIC RISK; GENOTYPE; HEALTH SURVEY; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC HYPERTENSION; BLOOD; BLOOD PRESSURE; GENETIC PREDISPOSITION; GENETICS; LONGITUDINAL STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; REGRESSION ANALYSIS;

AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BLOOD PRESSURE; CHOLESTEROL; DEMENTIA; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS;

EID: 0037031125     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-137-3-200208060-00006     Document Type: Article

References (30)

1. Serum total cholesterol, apolipoprotein E ε 4 allele, and Alzheimer's disease
2. Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal, population based study
3. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors
4. Statins and the risk of dementia
5. Far more than a lipid transport protein
6. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: A case-control study
7. APOE genotype, plasma lipids, lipoproteins, and AD in community elderly
8. APOE genotype predicts AD and other dementia but not ischemic cerebrovascular disease
9. The association between APOE and dementia does not seem to be mediated by vascular factors
10. 15-Year longitudinal study of blood pressure and dementia
11. Midlife blood pressure and dementia: The Honolulu-Asia aging study
12. Midlife cardiovascular risk factors, apoE, and cognitive decline in elderly male twins
13. The role of APOE ε in modulating effects of other risk factors for cognitive decline in elderly persons
14. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study
15. The effect of APOE on dementia is not through atherosclerosis: The Rotterdam Study
16. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset
17. Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular diseases (North Karelia project)
18. Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland
19. Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study
20. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
21. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals
22. Determination by PCR-RFLP of apo E genotype in a Japanese population
23. Neuropathology of Alzheimer's disease: What is new since A. Alzheimer?
24. Association of apolipoprorein E polymorphism with outcome after head injury
25. apoE genotype and survival from intracerebral haemorrhage
26. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis
27. Actual blood pressure control: Are we doing things right?
28. Control of blood pressure and risk of stroke among pharmacologically treated hypertensive patients
29. Cardiologists like statins-more than patients do